Health4 weeks ago
Hemogenyx and Cellin Technologies Pursue CAR-T Therapy in Estonia
Hemogenyx Pharmaceuticals has entered into a letter of intent with Cellin Technologies to investigate the commercialization of its HG-CT-1 CAR-T cell therapy targeting relapsed or refractory...